251 related articles for article (PubMed ID: 31767187)
1. Patient-derived explants, xenografts and organoids: 3-dimensional patient-relevant pre-clinical models in endometrial cancer.
Collins A; Miles GJ; Wood J; MacFarlane M; Pritchard C; Moss E
Gynecol Oncol; 2020 Jan; 156(1):251-259. PubMed ID: 31767187
[TBL] [Abstract][Full Text] [Related]
2. The Use of Endometrial Cancer Patient-Derived Organoid Culture for Drug Sensitivity Testing Is Feasible.
Girda E; Huang EC; Leiserowitz GS; Smith LH
Int J Gynecol Cancer; 2017 Oct; 27(8):1701-1707. PubMed ID: 28683005
[TBL] [Abstract][Full Text] [Related]
3. Efficient use of patient-derived organoids as a preclinical model for gynecologic tumors.
Maru Y; Tanaka N; Itami M; Hippo Y
Gynecol Oncol; 2019 Jul; 154(1):189-198. PubMed ID: 31101504
[TBL] [Abstract][Full Text] [Related]
4. Patient-derived organoids from endometrial disease capture clinical heterogeneity and are amenable to drug screening.
Boretto M; Maenhoudt N; Luo X; Hennes A; Boeckx B; Bui B; Heremans R; Perneel L; Kobayashi H; Van Zundert I; Brems H; Cox B; Ferrante M; Uji-I H; Koh KP; D'Hooghe T; Vanhie A; Vergote I; Meuleman C; Tomassetti C; Lambrechts D; Vriens J; Timmerman D; Vankelecom H
Nat Cell Biol; 2019 Aug; 21(8):1041-1051. PubMed ID: 31371824
[TBL] [Abstract][Full Text] [Related]
5. PTEN deficiency sensitizes endometrioid endometrial cancer to compound PARP-PI3K inhibition but not PARP inhibition as monotherapy.
Bian X; Gao J; Luo F; Rui C; Zheng T; Wang D; Wang Y; Roberts TM; Liu P; Zhao JJ; Cheng H
Oncogene; 2018 Jan; 37(3):341-351. PubMed ID: 28945226
[TBL] [Abstract][Full Text] [Related]
6. Development of a patient-derived explant model for prediction of drug responses in endometrial cancer.
Collins A; Miles GJ; Powley IR; Hew R; Pringle JH; MacFarlane M; Pritchard C; Moss EL
Gynecol Oncol; 2021 Feb; 160(2):557-567. PubMed ID: 33309417
[TBL] [Abstract][Full Text] [Related]
7. A novel integrated system using patient-derived glioma cerebral organoids and xenografts for disease modeling and drug screening.
Zhang L; Liu F; Weygant N; Zhang J; Hu P; Qin Z; Yang J; Cheng Q; Fan F; Zeng Y; Tang Y; Li Y; Tang A; He F; Peng J; Liao W; Hu Z; Li M; Liu Z
Cancer Lett; 2021 Mar; 500():87-97. PubMed ID: 33309780
[TBL] [Abstract][Full Text] [Related]
8. Single cell transcriptomes of normal endometrial derived organoids uncover novel cell type markers and cryptic differentiation of primary tumours.
Cochrane DR; Campbell KR; Greening K; Ho GC; Hopkins J; Bui M; Douglas JM; Sharlandjieva V; Munzur AD; Lai D; DeGrood M; Gibbard EW; Leung S; Boyd N; Cheng AS; Chow C; Lim JL; Farnell DA; Kommoss S; Kommoss F; Roth A; Hoang L; McAlpine JN; Shah SP; Huntsman DG
J Pathol; 2020 Oct; 252(2):201-214. PubMed ID: 32686114
[TBL] [Abstract][Full Text] [Related]
9. Organoid models in gynaecological oncology research.
Semertzidou A; Brosens JJ; McNeish I; Kyrgiou M
Cancer Treat Rev; 2020 Nov; 90():102103. PubMed ID: 32932156
[TBL] [Abstract][Full Text] [Related]
10. The antitumor effect of metformin with and without carboplatin on primary endometrioid endometrial carcinoma in vivo.
Schrauwen S; Coenegrachts L; Cattaneo A; Hermans E; Lambrechts D; Amant F
Gynecol Oncol; 2015 Aug; 138(2):378-82. PubMed ID: 26050920
[TBL] [Abstract][Full Text] [Related]
11. Patient-Derived Xenograft Models for Endometrial Cancer Research.
Moiola CP; Lopez-Gil C; Cabrera S; Garcia A; Van Nyen T; Annibali D; Fonnes T; Vidal A; Villanueva A; Matias-Guiu X; Krakstad C; Amant F; Gil-Moreno A; Colas E
Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30126113
[TBL] [Abstract][Full Text] [Related]
12. Challenges, applications and future directions of precision medicine in prostate cancer - the role of organoids and patient-derived xenografts.
Joshi A; Roberts MJ; Alinezhad S; Williams ED; Vela I
BJU Int; 2020 Jul; 126(1):65-72. PubMed ID: 32383524
[TBL] [Abstract][Full Text] [Related]
13. Human iPS Cell-Derived Patient Tissues and 3D Cell Culture Part 2: Spheroids, Organoids, and Disease Modeling.
Eglen RM; Reisine T
SLAS Technol; 2019 Feb; 24(1):18-27. PubMed ID: 30798678
[TBL] [Abstract][Full Text] [Related]
14. Assay Establishment and Validation of a High-Throughput Screening Platform for Three-Dimensional Patient-Derived Colon Cancer Organoid Cultures.
Boehnke K; Iversen PW; Schumacher D; Lallena MJ; Haro R; Amat J; Haybaeck J; Liebs S; Lange M; Schäfer R; Regenbrecht CR; Reinhard C; Velasco JA
J Biomol Screen; 2016 Oct; 21(9):931-41. PubMed ID: 27233291
[TBL] [Abstract][Full Text] [Related]
15. Organoids: An intermediate modeling platform in precision oncology.
Jin MZ; Han RR; Qiu GZ; Ju XC; Lou G; Jin WL
Cancer Lett; 2018 Feb; 414():174-180. PubMed ID: 29174804
[TBL] [Abstract][Full Text] [Related]
16. Patient-derived cancer modeling for precision medicine in colorectal cancer: beyond the cancer cell line.
Pyo DH; Hong HK; Lee WY; Cho YB
Cancer Biol Ther; 2020 Jun; 21(6):495-502. PubMed ID: 32208894
[TBL] [Abstract][Full Text] [Related]
17. Similarities and differences in metabolites of tongue cancer cells among two- and three-dimensional cultures and xenografts.
Murakami S; Tanaka H; Nakayama T; Taniura N; Miyake T; Tani M; Kushima R; Yamamoto G; Sugihara H; Mukaisho KI
Cancer Sci; 2021 Feb; 112(2):918-931. PubMed ID: 33244783
[TBL] [Abstract][Full Text] [Related]
18. Proteomic Analysis of Stromal and Epithelial Cell Communications in Human Endometrial Cancer Using a Unique 3D Co-Culture Model.
Al-Juboori AAA; Ghosh A; Jamaluddin MFB; Kumar M; Sahoo SS; Syed SM; Nahar P; Tanwar PS
Proteomics; 2019 Nov; 19(21-22):e1800448. PubMed ID: 30865368
[TBL] [Abstract][Full Text] [Related]
19. Old and new perspectives in the pharmacological treatment of advanced or recurrent endometrial cancer: Hormonal therapy, chemotherapy and molecularly targeted therapies.
Gadducci A; Cosio S; Genazzani AR
Crit Rev Oncol Hematol; 2006 Jun; 58(3):242-56. PubMed ID: 16436330
[TBL] [Abstract][Full Text] [Related]
20. Characterization of patient-derived tumor xenograft models of endometrial cancer for preclinical evaluation of targeted therapies.
Depreeuw J; Hermans E; Schrauwen S; Annibali D; Coenegrachts L; Thomas D; Luyckx M; Gutierrez-Roelens I; Debruyne D; Konings K; Moerman P; Vergote I; Lambrechts D; Amant F
Gynecol Oncol; 2015 Oct; 139(1):118-26. PubMed ID: 26232337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
